Epiminder Limited (ASX:EPI)

Market Cap	93.03M
Revenue (ttm)	648.18K -87.5%
Net Income	-38.14M
EPS	-0.44
Shares Out	216.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	148,935
Average Volume	101,668
Open	0.4300
Previous Close	0.4300
Day's Range	0.4050 - 0.4300
52-Week Range	0.4050 - 1.4900
Beta	n/a
RSI	30.35
Earnings Date	Aug 31, 2026

About Epiminder

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wireles...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPI

Financial Performance

In fiscal year 2025, Epiminder's revenue was 445,183, a decrease of -91.52% compared to the previous year's 5.25 million. Losses were -31.78 million, 91.5% more than in 2024.